Irvine, CA (PRWEB) May 12, 2022 Fluxergy has joined as an inaugural member of the Wyss Diagnostics Accelerator’s (Wyss DxA) Industrial Participant Program
pfonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pfonline.com Daily Mail and Mail on Sunday newspapers.
Image from Fluxergy s factory floor courtesy of Fluxergy The company’s longer-term goal is to develop the platform to provide “multiple points of information from a single test,” says President Tej Patel.
Fluxergy, a company that has already made headlines for earning a CE mark for its one-hour COVID-19 RT-PCR test, has expanded its U.S. headquarters after commercializing the test globally. The expansion will enable the company to ramp up production of the rapid test as well as further develop the test platform for other uses.
The new 30,000-sq-m facility, located at 15 Musick in Irvine, CA, is essentially across the street from Fluxergy’s existing buildings and will feature the company’s modular approach to in-house manufacturing. When fully operational, the facility is expected to produce one million COVID-19 test kits per month for distribution in Europe, the Middle East, Africa, and Taiwan.
Image by ronstik - Adobe Stock Fluxergy is looking for partners to help bring its CE-marked COVID-19 test to market. The automated testing platform has multimodal capability allowing for a variety of assay types to be run simultaneously on the same cartridge.
Fluxergy, a medical diagnostic testing platform company with a detection technology solution capable of multimodality, recently received CE marking for its one-hour COVID-19 RT-PCR test, to use by healthcare professionals as an
in vitro diagnostic for the detection of SARS-CoV-2.
“One of the big things that we’ve been developing over the last eight years has been multimodality technologies,” Fluxergy President Tej Patel told